...
首页> 外文期刊>Clinical and experimental ophthalmology >Intravitreal pefloxacin therapy in postoperative endophthalmitis.
【24h】

Intravitreal pefloxacin therapy in postoperative endophthalmitis.

机译:玻璃体腔培氟沙星治疗术后眼内炎。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To study the efficacy of intravitreal pefloxacin in the management of suspected bacterial endophthalmitis. METHODS: Twenty eyes with suspected postoperative bacterial endophthalmitis were given an intravitreal injection of pefloxacin (200 microg in 0.1 mL). If required the injection was repeated after 24 h. The main parameters evaluated were visual acuity, response to intravitreal therapy and any complications due to intravitreal pefloxacin. RESULTS: Fourteen eyes (70%) responded to intravitreal pefloxacin therapy alone, while an additional pars plana vitrectomy was required in six eyes (30%). Nineteen eyes retained a visual acuity of 6/60 or better at 3 months after the initiation of therapy. A retinal detachment developed in one of the eyes which received intravitreal therapy. CONCLUSIONS: Intravitreal pefloxacin may be a useful aternative therapy in bacteria endophthalmitis.
机译:目的:研究玻璃体内培氟沙星治疗可疑细菌性眼内炎的疗效。方法:对二十只疑似术后细菌性眼内炎的眼睛进行玻璃体腔注射培氟沙星(0.1毫升中含200微克)。如果需要,在24小时后重复注射。评估的主要参数是视敏度,对玻璃体内治疗的反应以及玻璃体内培氟沙星引起的任何并发症。结果:仅玻璃体内培氟沙星治疗对十四只眼(70%)有反应,而六只眼(30%)需要额外的平面玻璃体切除术。开始治疗后3个月,有19只眼的视力保持在6/60或更高。接受玻璃体内治疗的一只眼睛出现了视网膜脱离。结论玻璃体内培氟沙星可能是细菌性眼内炎的有效替代疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号